Key facts
- It has raised $1.1M across 1 recorded rounds; the latest was Seed Round ($750K) in May 2025.
- ThetaRho has filed 2 Form Ds with the SEC since 2023, most recently May 2025 ( sold).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for ThetaRho
Funding rounds
1 roundsAbout ThetaRho
Developer of a software-as-a-service-based application designed to transform administrative processes in healthcare. The platform offers a natural language interface for retrieving contextual data during visits, automates administrative tasks such as prescription orders and referrals, and generates visit summaries and inbox responses, while also providing timely access to health information and automated scheduling tools, enabling healthcare providers to reduce administrative burden and focus more on patient care.
- Sector
- Healthcare
- HQ
- San Jose, CA, United States
- Founded
- 2023
- Employees
- 10
- Website
- thetarho.ai/
- Ownership
- Privately Held (backing)
ThetaRho doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ThetaRho shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ThetaRho in its N-PORT filings yet. We sweep new filings monthly.